Dipeptidyl peptidase-4 inhibition prevents vascular dysfunction induced by β-adrenergic hyperactivity
Chronic stimulation of the β-adrenergic sympathetic system induces vascular dysfunction which is associated with increased inflammatory cytokines production. A recently proposed therapy to control vascular injury through inflammatory processes involves inhibition of the enzyme dipeptidyl peptidase-I...
Main Authors: | Bruna Coelho de Oliveira, Vinicius Bermond Marques, Bruna Ferro Brun, Hadassa Miranda de Oliveira e Silva, Stéphano Freitas Soares Melo, Edilamar Menezes de Oliveira, Leonardo dos Santos, Valério Garrone Barauna |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218355069 |
Similar Items
-
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors
by: Atsushi Tanaka, et al.
Published: (2021-02-01) -
Dipeptidyl peptidase IV and its implication in cancer
by: Yarini M Arrebola, et al. -
Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2
by: Cynthia Melissa Valerio, et al.
Published: (2017-04-01) -
Association between Serum Dipeptidyl Peptidase-4 Concentration and Obesity-related Factors in Health Screen Examinees
by: Ji Yeon Lee, et al.
Published: (2017-09-01) -
The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo
by: Masako Uchii, et al.
Published: (2017-11-01)